Do you have the same question? Follow this Question
Jun 19, 2025 - 11:36 AM
We’ve provided several answers to questions related to Zeposia (Ozanimod) , see some other helpful Q&A related to this product.
Question: What should be done if a rare brain infection is suspected while on this medication?
Answer: If symptoms of a rare brain infection like PML occur, such as unusual weakness or vision changes, stop taking the medication and contact a doctor immediately. Prompt action can prevent serious complications, ensuring patient safety.
Question: What conditions is the medication used to treat?
Answer: The medication is used for treating relapsing forms of multiple sclerosis (MS) and moderately to severely active ulcerative colitis (UC). It helps manage symptoms by reducing inflammation and nerve damage, improving patients' quality of life.
Question: What are the dosage strengths available for this medication?
Answer: The medication is available in 0.23 mg, 0.46 mg, and 0.92 mg capsules. These varying strengths allow for a tailored titration period, ensuring that patients can gradually increase the dose to minimize side effects.
Question: What is the formula of the active ingredient in the medication?
Answer: The formula of the active ingredient, Ozanimod, is C23H24N4O3. This chemical composition is crucial for its function as a sphingosine 1-phosphate receptor modulator, which helps in reducing inflammation by limiting white blood cells' movement.
